FrancophonIA/ELRC3.0 huggingface dataset:
English: Refractory invasive fungal infections (IFI)/patients with IFI intolerant to 1
Slovenian: Rezistentne invazivne glivne okužbe/bolniki z rezistentno glivno okužbo, ki ne prenašajo zdravljenja 1. izbora
English: hypertension hypotension, thrombophlebitis, vasculitis
Slovenian: hipertenzija hipotenzija, tromboflebitis, vaskulitis
English: The recommended dose is 200 mg (one 5 mL spoonful) taken four times daily.
Slovenian: Priporočeni odmerek je 200 mg (ena polna 5 ml žlička) štirikrat na dan.
English: • feeling weak, dizzy, tired or sleepy
Slovenian: • šibkost, omotičnost, utrujenost ali zaspanost
English: C-posaconazole as oral suspension, radioactivity was predominantly recovered in the faeces (77 % of the radiolabelled dose) with the major component being parent compound (66 % of the radiolabelled dose).
Slovenian: Po uporabi C-posakonazola v obliki peroralne suspenzije se je radioaktivnost pojavila predvsem v blatu (77 % radioaktivno označenega odmerka); glavni del tega je bila matična spojina (66 % radioaktivno označenega odmerka).
English: • abnormal skin sensations, such as numbness, tingling, itching, creeping, pricking or burning
Slovenian: • nenormalne zaznave na koži, na primer omrtvelost, mravljinčenje, srbenje, gomazenje, zbadanje ali pekoč občutek
English: Effect of food on oral absorption in healthy volunteers The absorption of posaconazole was significantly increased when posaconazole 400 mg (once daily) was administered during and immediately after the consumption of a high fat meal (~ 50 grams fat) compared to administration before a meal, with Cmax and AUC increasing by approximately 330 % and 360 %, respectively.
Slovenian: Vpliv hrane na peroralno absorpcijo pri zdravih prostovoljcih Absorpcija posakonazola se je bistveno povečala, če so bolniki zaužili posakonazol v odmerku 400 mg (enkrat na dan) ob obroku z veliko količino maščob (~ 50 gramov maščobe) oziroma takoj po takšnem obroku, v primerjavi z jemanjem zdravila pred obrokom.
English: How to use Noxafil
Slovenian: Kako uporabljati zdravilo Noxafil
English: Noxafil concentrate for solution for infusion should be inspected visually for particulate matter prior to administration.
Slovenian: Zdravilo Noxafil koncentrat za raztopino za infundiranje je treba pred uporabo pregledati, da ne vsebuje delcev.
English: Do not use Noxafil
Slovenian: Ne uporabljajte zdravila Noxafil
English: Posaconazole plasma concentrations following administration of posaconazole tablets may increase over time in some patients.
Slovenian: Plazemske koncentracije posakonazola se lahko po uporabi tablet pri nekaterih bolnikih sčasoma povečajo.
English: The recommended dose is 300 mg twice a day on the first day, then 300 mg once a day, thereafter.
Slovenian: Priporočeni odmerek je 300 mg dvakrat na dan prvi dan in nato 300 mg enkrat na dan.
English: Sirolimus concentrations should be measured upon initiation, during co-administration, and at discontinuation of posaconazole treatment, with sirolimus doses adjusted accordingly.
Slovenian: Koncentracijo sirolimusa je treba izmeriti ob uvedbi zdravljenja, med sočasno uporabo in tudi ob ukinitvi zdravljenja s posakonazolom in po potrebi ustrezno prilagoditi odmerke sirolimusa.
English: Lactated Ringer's solution 5 % dextrose with Lactated Ringer's solution 4.2 % sodium bicarbonate
Slovenian: Zdravila Noxafil se ne sme razredčiti z: raztopino Ringerjevega laktata 5 % glukozo z raztopino Ringerjevega laktata 4,2 % raztopino natrijevega hidrogenkarbonata
English: Based on Kaplan-Meier estimates, the probability of survival up to day 100 after randomisation, was significantly higher for posaconazole recipients; this survival benefit was demonstrated when the analysis considered all causes of death (P= 0.0354) as well as IFI-related deaths (P = 0.0209).
Slovenian: Ta koristen vpliv na preživetje so dokazali, ko so v analizi upoštevali vse vzroke smrti (p = 0,0354), pa tudi smrti, povezane z invazivno glivno okužbo (p = 0,0209).
English: Maximum duration of exposure to the concentrate for solution for infusion was shorter than with the oral suspension.
Slovenian: Najdaljša izpostavljenost zdravilu v koncentratu za raztopino za infundiranje je bila krajša kot izpostavljenost zdravilu v obliki peroralne suspenzije.
English: It is, therefore, suggested to closely monitor for breakthrough fungal infections in patients weighing more than 120 kg.
Slovenian: Zato je bolnike, ki tehtajo več kot 120 kg, priporočljivo skrbno spremljati glede prebijajočih glivnih okužb.
English: Do not take Noxafil
Slovenian: Ne jemljite zdravila Noxafil
English: Do not take Noxafil if you are pregnant unless you are told to by your doctor.
Slovenian: Če ste noseči, ne jemljite zdravila Noxafil, razen če vam to naroči zdravnik.
English: Each mL contains 18 mg of posaconazole.
Slovenian: En mililiter vsebuje 18 mg posakonazola.
English: Thereafter blood levels of ciclosporin should be monitored carefully during co-administration, and upon discontinuation of posaconazole treatment, and the dose of ciclosporin should be adjusted as necessary.
Slovenian: Potem je treba natančno spremljati koncentracije ciklosporina v krvi, in sicer med sočasno uporabo in po prenehanju zdravljenja s posakonazolom; odmerek ciklosporina je treba prilagoditi, kot je potrebno.
English: Increased systolic and arterial blood pressures (up to 29 mm-Hg) were seen in rats and monkeys at systemic exposures 1.4-fold and 4.6-fold greater, respectively, than those achieved with the human therapeutic doses.
Slovenian: Zvišan sistolični in arterijski krvni tlak (do 29 mmHg) so opažali pri podganah oz. opicah pri sistemskih izpostavljenostih, ki so bile 1,4-krat oz. 4,6-krat večje od izpostavljenosti, doseženih s terapevtskimi odmerki pri človeku.
English: There are limited pharmacokinetic data in patients with severe gastrointestinal dysfunction (such as severe diarrhoea).
Slovenian: Za bolnike s hudimi motnjami v delovanju prebavil (npr. s hudo drisko) je na voljo malo farmakokinetičnih podatkov.
English: Musculoskeletal and connective tissue disorders
Slovenian: Bolezni mišično-skeletnega sistema in vezivnega tkiva Občasni:
English: If you are not sure, talk to your doctor or pharmacist before taking Noxafil.
Slovenian: Če ste negotovi, se posvetujte z zdravnikom ali farmacevtom, preden vzamete zdravilo Noxafil.
English: Serial PK samples were collected on Day 1 and at steady-state on Day 8 for all Part 1 subjects and a subset of Part 2 subjects.
Slovenian: Zaporedne farmakokinetične vzorce so vzeli 1. dan in v stanju dinamičnega ravnovesja 8. dan, in sicer vsem preiskovancem iz dela 1 in podskupini preiskovancev iz dela 2.
English: Take 200 mg (one 5 mL spoonful) three times a day.
Slovenian: Jemljite 200 mg (eno polno 5 ml žličko) trikrat na dan.
English: Noxafil should be administered with caution to patients with pro-arrhythmic conditions such as:
Slovenian: Zdravilo Noxafil je treba uporabljati previdno pri bolnikih z bolezenskimi stanji, ki povečajo nagnjenost k motnjam srčnega ritma, kot so:
English: thrombocytopenia, leukopenia, anaemia, eosinophilia, lymphadenopathy, splenic infarction
Slovenian: trombocitopenija, levkopenija, anemija, eozinofilija, limfadenopatija, vranični infarkt
English: Noxafil is also available as 100 mg gastro-resistant tablet and 300 mg concentrate for solution for infusion.
Slovenian: Zdravilo Noxafil je na voljo tudi v obliki 100-miligramskih gastrorezistentnih tablet in 300-miligramskega koncentrata za raztopino za infundiranje.
English: Excipients: Betadex Sulfobutyl Ether Sodium (SBECD), disodium edetate, hydrochloric acid and sodium hydroxide (for pH adjustment), water for injections.
Slovenian: Pomožne snovi: natrijev sulfobutileter betaciklodekstrin (SBECD), dinatrijev edetat, klorovodikova kislina in natrijev hidroksid (za prilagoditev pH), voda za injekcije
English: Please refer to the Summary of Product Characteristics of Noxafil oral suspension for use in oropharyngeal candidiasis.
Slovenian: Za uporabo pri orofaringealni kandidozi glejte povzetek glavnih značilnosti zdravila Noxafil peroralna suspenzija.
English: There is no experience with overdose of posaconazole tablets.
Slovenian: Izkušenj s prevelikim odmerjanjem tablet posakonazola ni.
English: Posaconazole plasma concentrations following administration of posaconazole tablets may increase over time in some patients (see section 5.2).
Slovenian: Koncentracije posakonazola v plazmi se lahko po uporabi tablet pri nekaterih bolnikih sčasoma povečajo (glejte poglavje 5.2).
English: • infections caused by fungi of the Aspergillus family that have not improved during treatment with the anti-fungal medicines amphotericin B or itraconazole or when these medicines have had to be stopped;
Slovenian: • okužb, ki jih povzročajo glive iz družine Aspergillus in ki se niso izboljšale med zdravljenjem s protiglivnima zdraviloma amfotericin B ali itrakonazol, ali če je bilo treba ti dve zdravili ukiniti;
English: Intravenous use after dilution
Slovenian: intravenska uporaba po razredčenju viala za enkratno uporabo
English: See also below regarding the effect of posaconazole on rifabutin plasma levels.
Slovenian: Glede vpliva posakonazola na koncentracije rifabutina v plazmi glejte tudi spodaj.
English: Control Proportion (%) of patients with proven/probable Aspergillosis On-treatment period
Slovenian: Kontrolna skupina Odstotek (%) bolnikov z dokazano oziroma verjetno aspergilozo Obdobje zdravljenja
English: There is no paediatric experience with posaconazole concentrate for solution for infusion (see sections 4.2 and 5.3).
Slovenian: Izkušenj s posakonazolom v koncentratu za raztopino za infundiranje pri pediatričnih bolnikih ni (glejte poglavji 4.2. in 5.3).
English: • low level of “leukocytes” a type of white blood cell (leukopenia) shown in blood tests - this can make you more likely to get infections
Slovenian: • nizko število levkocitov - belih krvnih celic (levkopenija) - pokaže se na preiskavah krvi; poveča lahko verjetnost za okužbe
English: Each vial contains 300 mg of posaconazole.
Slovenian: Ena viala vsebuje 300 mg posakonazola.
English: Following administration of 800 mg per day of posaconazole oral suspension as a divided dose for treatment of invasive fungal infections, mean trough plasma concentrations from 12 patients 817 years of age (776 ng/mL) were similar to concentrations from 194 patients 18 - 64 years of age
Slovenian: Po uporabi peroralne suspenzije posakonazola 800 mg na dan v deljenih odmerkih za zdravljenje invazivnih glivnih okužb je bila povprečna najmanjša plazemska koncentracija pri 12 bolnikih, starih od 8 do 17 let (776 ng/ml), podobna kot pri 194 bolnikih, starih od 18 do 64 let (817 ng/ml).
English: Monitoring of patients with severe renal impairment Due to the variability in exposure, patients with severe renal impairment should be monitored closely for breakthrough fungal infections (see sections 4.2 and 5.2).
Slovenian: Zaradi razlik v izpostavljenosti je treba bolnike s hudo okvaro ledvic skrbno spremljati glede prebijajočih (breakthrough) glivnih okužb (glejte poglavji 4.2 in 5.2).
English: nausea vomiting, abdominal pain, diarrhoea, dyspepsia, dry mouth, flatulence, constipation, anorectal discomfort
Slovenian: navzea bruhanje, bolečine v trebuhu, driska, dispepsija, suha usta, flatulenca, zaprtje, anorektalno nelagodje
English: Paediatric population There is no paediatric experience for posaconazole tablets.
Slovenian: Pediatrična populacija Izkušenj s tabletami posakonazola pri pediatričnih bolnikih ni.
English: After a single oral dose of 400 mg posaconazole oral suspension to patients with mild (Child-Pugh Class A), moderate (Child-Pugh Class B) or severe (Child-Pugh Class C) hepatic impairment (six per group), the mean AUC was 1.3 to 1.6-fold higher compared to that for matched control subjects with normal hepatic function.
Slovenian: Po enkratnem peroralnem odmerku 400 mg peroralne suspenzije posakonazola pri bolnikih z blago (razred A po Child-Pughu), zmerno (razred B po Child-Pughu) ali hudo okvaro jeter (razred C po Child-Pughu) (po šest bolnikov na skupino) je bila povprečna AUC od 1,3- do 1,6- krat večja kot pri odgovarjajočih preiskovancih iz kontrolne skupine, ki so imeli normalno delovanje jeter.
English: No difference in the incidence of brain ventricle enlargement between control and treated animals was observed following the subsequent 5-month treatment-free period.
Slovenian: Po nadaljnjem 5-mesečnem obdobju brez zdravila med kontrolno skupino živali in skupino, ki je dobivala zdravilo, niso opazili razlike v pojavnosti povečanja možganskih prekatov.
English: • inflammation of the blood vessels
Slovenian: • vnetje krvnih žil
English: Sixteen patients 8-17 years of age were treated with posaconazole oral suspension 800 mg/day in a study for invasive fungal infections.
Slovenian: Šestnajst bolnikov, starih od 8 do 17 let, so v študiji invazivnih glivnih okužb zdravili s peroralno suspenzijo posakonazola v odmerku 800 mg/dan.
English: long QT syndrome
Slovenian: sindrom dolgega QT
English: Each gastro-resistant tablet contains 100 mg of posaconazole.
Slovenian: Ena gastrorezistentna tableta vsebuje 100 mg posakonazola.
English: hepatocellular damage, hepatitis, jaundice, hepatomegaly, cholestasis, hepatic toxicity, hepatic function abnormal
Slovenian: okvara jetrnih celic, hepatitis, zlatenica, hepatomegalija, holestaza, hepatotoksičnost, nenormalno delovanje jeter
English: Increased systolic and arterial blood pressures (up to 29 mm-Hg) were seen in rats and monkeys at systemic exposures 2.2-fold and 8.9-fold greater, respectively, than those achieved with the human therapeutic doses.
Slovenian: Zvišan sistolični in arterijski krvni tlak (do 29 mmHg) so opažali pri podganah oz. opicah pri sistemskih izpostavljenostih, ki so bile 2,2-krat oz. 8,9-krat večje od izpostavljenosti, doseženih s terapevtskimi odmerki pri človeku.
English: Posaconazole, after administration of 300 mg of posaconazole concentrate for solution for infusion, is slowly eliminated with a mean half-life (t½) of 27 hours and a mean clearance of 7.3 L/hr.
Slovenian: Po uporabi 300 mg posakonazola v koncentratu za raztopino za infundiranje je izločanje posakonazola počasno; povprečni razpolovni čas (t1/2) je 27 ur in povprečni očistek 7,3 l/uro.
English: The pharmacokinetics of posaconazole concentration for solution for infusion are comparable in men and women.
Slovenian: Farmakokinetika posakonazola v koncentratu za raztopino za infundiranje je pri moških in ženskah primerljiva.
English: hepatic failure, hepatitis cholestatic, hepatosplenomegaly, liver tenderness, asterixis
Slovenian: odpoved jeter, holestatski hepatitis, hepatosplenomegalija, občutljivost jeter, asteriksis
English: Plasma exposure resulting from the solution for infusion was higher than observed with the oral suspension.
Slovenian: Plazemska izpostavljenost zdravilu iz raztopine za infundiranje je bila večja od tiste, ki so jo opazili pri peroralni suspenziji.
English: The pharmacokinetics of posaconazole concentrate for solution for infusion are comparable in young and elderly subjects.
Slovenian: Farmakokinetika posakonazola v koncentratu za raztopino za infundiranje je pri mlajših in pri starejših bolnikih primerljiva.
English: Common:
Slovenian: c:
English: Proportion (%) of patients with proven/probable Aspergillosis On-treatment period
Slovenian: Odstotek (%) bolnikov z dokazano oziroma verjetno aspergilozo Obdobje zdravljenja
English: Concomitant use of posaconazole and efavirenz should be avoided unless the benefit to the patient outweighs the risk.
Slovenian: Sočasni uporabi posakonazola in efavirenza se je treba izogibati, razen če korist za bolnika odtehta tveganje.
English: Noxafil 300 mg concentrate for solution for infusion posaconazole
Slovenian: Noxafil 300 mg koncentrat za raztopino za infundiranje posakonazol
English: • “haemolytic uraemic syndrome” when red blood cells breakup (hemolysis) which may happen with or without kidney failure
Slovenian: • hemolitično-uremični sindrom, ki se pojavi zaradi razpadanja rdečih krvnih celic (hemoliza),
English: • infections caused by a fungus called Coccidioides that have not improved during treatment with one or more of amphotericin B, itraconazole or fluconazole or when these medicines have had to be stopped.
Slovenian: • okužb, ki jih povzročajo glive Coccidioides, ki se niso izboljšale med zdravljenjem z enim ali več od naslednjih zdravil: amfotericinom B, itrakonazolom ali flukonazolom, ali če je bilo treba zdravljenje s temi zdravili končati.
English: Noxafil concentrate for solution for infusion should not be given by bolus administration.
Slovenian: Zdravila Noxafil koncentrat za raztopino za infundiranje se ne sme dati kot bolus.
English: Increased systolic and arterial blood pressures (up to 29 mm-Hg) were seen in rats and monkeys at systemic exposures 2.1-fold and 8.5-fold greater, respectively, than those achieved with the human therapeutic doses.
Slovenian: Zvišan sistolični in arterijski krvni tlak (do 29 mmHg) so opažali pri podganah oz. opicah pri sistemskih izpostavljenostih, ki so bile 2,1-krat oz. 8,5-krat večje od izpostavljenosti, doseženih s terapevtskimi odmerki pri človeku.
English: Noxafil 300 mg concentrate for solution for infusion
Slovenian: Noxafil 300 mg koncentrat za raztopino za infundiranje
English: Posaconazole had no effect on fertility of male rats at doses up to 180 mg/kg (3.4 times the 300-mg tablet based on steady-state plasma concentrations in patients) or female rats at a dose up to 45 mg/kg (2.6 times the 300-mg tablet based on steady-state plasma concentrations in patients).
Slovenian: Posakonazol ni vplival na plodnost podganjih samcev v odmerkih do 180 mg/kg (3,4-kratnik v primerjavi z uporabo 300-mg tablet na podlagi plazemske koncentracije v stanju dinamičnega ravnovesja pri bolnikih) ali podganjih samic v odmerku do 45 mg/kg (2,6-kratnik v primerjavi z uporabo 300-mg tablet na podlagi plazemske koncentracije v stanju dinamičnega ravnovesja pri bolnikih).
English: Posaconazole does not have any major circulating metabolites.
Slovenian: Posakonazol v obtoku nima nobenega glavnega presnovka.
English: Thereafter blood levels of tacrolimus should be monitored carefully during co-administration, and upon discontinuation of posaconazole, and the dose of tacrolimus should be adjusted as necessary.
Slovenian: Potem je treba natančno spremljati koncentracijo takrolimusa v krvi, in sicer med sočasno uporabo in po prenehanju zdravljenja s posakonazolom; odmerek takrolimusa je treba prilagoditi, kot je potrebno.
English: Posaconazole concentrations may be significantly lowered in combination; therefore, concomitant use with posaconazole should be avoided unless the benefit to the patient outweighs the risk (see section 4.5).
Slovenian: Zato se je treba izogibati njihovi sočasni uporabi s posakonazolom, razen če korist za bolnika odtehta tveganje (glejte poglavje 4.5).
English: Noxafil 100 mg gastro-resistant tablets posaconazole
Slovenian: Noxafil 100 mg gastrorezistentne tablete posakonazol
English: Frequent monitoring for adverse reactions and toxicity related to antiretroviral agents that are substrates of CYP3A4 is recommended during coadministration with posaconazole.
Slovenian: Med sočasno uporabo posakonazola je priporočljivo pogosto spremljanje glede neželenih učinkov in toksičnosti, povezanih s protiretrovirusnimi zdravili, ki so substrati CYP3A4.
English: Clear, colourless to yellow liquid.
Slovenian: koncentrat za raztopino za infundiranje bistra, brezbarvna do rumena tekočina
English: A non-dose related incidence of thrombus/emboli in the lung was seen in the 1 month repeated dose study in the monkey.
Slovenian: V 1-mesečni študiji ponavljajočih se odmerkov so pri opicah opazili pojavnost trombusov/embolusov v pljučih, ki ni bila povezana z odmerkom.
English: Safety data at higher exposure levels achieved with posaconazole concentrate for solution for infusion are at present limited.
Slovenian: Trenutno je na voljo malo podatkov o varnosti pri večji izpostavljenosti zdravilu po uporabi posakonazola v koncentratu za raztopino za infundiranje.
English: Do not adapt your dose yourself before consulting your doctor or change your treatment regime.
Slovenian: Brez posvetovanja z zdravnikom si odmerka ali režima zdravljenja ne smete spreminjati sami.
English: Morphine sulphate Norepinephrine bitartrate Potassium chloride Vancomycin hydrochloride
Slovenian: amikacinijev sulfat ciprofloksacin daptomicin dobutaminijev klorid famotidin filgrastim gentamicinijev sulfat hidromorfonijev klorid kalijev klorid kaspofungin levofloksacin lorazepam meropenem mikafungin morfinijev sulfat noradrenalinijev bitartrat vankomicinijev klorid
English: The pharmacokinetics of posaconazole tablets are comparable in young and elderly subjects.
Slovenian: Farmakokinetika tablet posakonazola je pri mlajših in pri starejših bolnikih primerljiva.
English: cough, epistaxis, hiccups, nasal congestion, pleuritic pain, tachypnoea pulmonary hypertension, interstitial pneumonia, pneumonitis
Slovenian: kašelj, krvavitev iz nosu, kolcanje, zamašen nos, plevritična bolečina, tahipneja pljučna hipertenzija, intersticijska pljučnica, pnevmonitis
English: Steadystate plasma concentrations are attained by Day 6 at the 300 mg dose (once daily after twice daily loading dose at Day 1).
Slovenian: Plazemska koncentracija v stanju dinamičnega ravnovesja je dosežena do 6. dne pri uporabi 300 mg odmerka (enkrat na dan po začetnem odmerku dvakrat na dan 1. dan).
English: If you become pregnant while you are using Noxafil, contact your doctor straight away.
Slovenian: Če med uporabo zdravila Noxafil zanosite, se nemudoma posvetujte z zdravnikom.
English: Tell your doctor if you are or think you are pregnant before you start to take Noxafil.
Slovenian: Če ste noseči ali menite, da bi lahko bili noseči, se posvetujte z zdravnikom, preden začnete z zdravljenjem z zdravilom Noxafil.
English: 9 of 11 patients were successfully treated with posaconazole oral suspension 800 mg/day in divided doses for a median of 268 days and up to 377 days.
Slovenian: 9 od 11 bolnikov so uspešno zdravili s peroralno suspenzijo posakonazola 800 mg/dan v deljenih odmerkih.
English: Due to the risk of prolonged sedation it is recommended that dose adjustments should be considered when posaconazole is administered concomitantly with any benzodiazepine that is metabolised by CYP3A4 (e.g. midazolam, triazolam, alprazolam) (see section 4.4).
Slovenian: Zaradi tveganja za dolgotrajnejšo sedacijo, je v primeru sočasne uporabe posakonazola in katerega koli benzodiazepina, ki se presnovi s CYP3A4 (npr. midazolama, triazolama ali alprazolama), priporočljivo razmisliti o prilagoditvi odmerka (glejte poglavje 4.4).
English: First time treatment of Thrush On the first day of treatment take 200 mg (one 5 mL spoonful) once.
Slovenian: Prvi dan zdravljenja zaužijte enkrat 200 mg (eno polno 5 ml žličko).
English: Following co-administration of posaconazole oral suspension (400 mg twice daily) with atazanavir and ritonavir (300/100 mg once daily) for 7 days in healthy subjects Cmax and AUC of atazanavir increased by an average of 1.5-fold and 2.5-fold (range 0.9 to 4.1-fold), respectively.
Slovenian: Po 7-dnevni sočasni uporabi peroralne suspenzije posakonazola (400 mg dvakrat na dan) z atazanavirjem in ritonavirjem (300/100 mg enkrat na dan) se je pri zdravih preiskovancih Cmax atazanavirja povečala v povprečju za 1,5-krat, njegova AUC pa za 2,5-krat (razpon od 0,9-krat do 4,1-krat).
English: • mucosal inflammation
Slovenian: • zvišana telesna temperatura
English: Paediatric population There is no paediatric experience for posaconazole concentrate for solution for infusion.
Slovenian: Pediatrična populacija Izkušenj s posakonazolom v koncentratu za raztopino za infundiranje pri pediatričnih bolnikih ni.
English: There is no experience with overdose of posaconazole concentrate for solution for infusion.
Slovenian: Izkušenj s prevelikim odmerjanjem posakonazola v koncentratu za raztopino za infundiranje ni.
English: The infusion solution should be inspected visually for particulate matter prior to administration.
Slovenian: Raztopino za infundiranje je treba pred uporabo pregledati, da ne vsebuje delcev.